Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SIMPLAAFY Clinical Trial

NCT: NCT06521463 · ACTIVE_NOT_RECRUITING

NCT IDNCT06521463
StatusACTIVE_NOT_RECRUITING
Start Date2024-10-01
Completion2027-01

Brief Summary

The primary objective is to demonstrate the safety and effectiveness of two monotherapy regimens versus dual antiplatelet (DAPT) therapy following post-implant with the WATCHMAN FLX Pro device in a commercial clinical setting.

Frequently Asked Questions

What is SIMPLAAFY Clinical Trial?

SIMPLAAFY Clinical Trial is a clinical trial registered under NCT06521463. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06521463?

The current status of NCT06521463 (SIMPLAAFY Clinical Trial) is: ACTIVE_NOT_RECRUITING.

When did SIMPLAAFY Clinical Trial start?

SIMPLAAFY Clinical Trial started on 2024-10-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑